Early maternal DHA supplementation fails to modify clinical phenotypes associated with impaired placentation: A randomized, double-blind, placebo-controlled trial (DEEPER trial)
Placenta · 2026-05 · 179 · 145-151
DOI: 10.1016/j.placenta.2026.04.013 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift Placenta, 2026-05. Verfasst von Jorge A Carvajal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Obstetricia, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Red de Salud UC Christus, Santiago, Chil…. Hauptthemen laut MEDLINE: Dietary Supplements, Docosahexaenoic Acids, Placentation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Non-US Government Research Support type, National Agency for Research and Development, Comisión Nacional de Investigación Científica y Tecnológica.
Abstract (Originalsprache)
BACKGROUND: Defective deep placentation contributes to major obstetric complications, including preterm birth, preeclampsia (PE), and severe fetal growth restriction (FGR). Docosahexaenoic acid (DHA) supplementation may improve placental function, but evidence from randomized trials remains inconsistent. OBJECTIVE: To evaluate whether early DHA supplementation modifies clinical phenotypes associated with impaired placentation. METHODS: In this multicenter, double-blind, placebo-controlled trial (NCT02336243), singleton pregnant women
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Obstetricia, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Red de Salud UC Christus, Santiago, Chile. Electronic address: jcarva@med.puc.cl.
- Departamento de Obstetricia, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Red de Salud UC Christus, Santiago, Chile.
- Departamento de Obstetricia, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Red de Salud UC Christus, Santiago, Chile. Electronic address: kmaraujo@uc.cl.
- Departamento de Medicina Familiar, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Red de Salud UC Christus, Santiago, Chile.
Förderung
- Non-US Government Research Support type
- National Agency for Research and Development
- Comisión Nacional de Investigación Científica y Tecnológica
Zitieren
APA
Carvajal, J. A., Carvajal, S. A., Araujo, K., Rojas, M. P., Casanello, P. C., & Vera, C. M. (2026). Early maternal DHA supplementation fails to modify clinical phenotypes associated with impaired placentation: A randomized, double-blind, placebo-controlled trial (DEEPER trial). Placenta, 179, 145-151. https://doi.org/10.1016/j.placenta.2026.04.013
Vancouver
Carvajal JA, Carvajal SA, Araujo K, Rojas MP, Casanello PC, Vera CM. Early maternal DHA supplementation fails to modify clinical phenotypes associated with impaired placentation: A randomized, double-blind, placebo-controlled trial (DEEPER trial). Placenta. 2026;179:145-151. doi:10.1016/j.placenta.2026.04.013
BibTeX
@article{Carvajal2026,
author = {Carvajal, Jorge A and Carvajal, Sergio A and Araujo, Kenny and Rojas, Maria P and Casanello, Paola C and Vera, Claudio M},
title = {Early maternal DHA supplementation fails to modify clinical phenotypes associated with impaired placentation: A randomized, double-blind, placebo-controlled trial (DEEPER trial)},
journal = {Placenta},
year = {2026},
volume = {179},
pages = {145--151},
doi = {10.1016/j.placenta.2026.04.013}
}
EUVIMED